Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
August 11, 2022
A five-year, $1.95 million grant to research novel pathways through which endothelial cells, the inner cellular lining of blood vessels, control inflammation has been awarded to UTHealth Houston researcher Jessica C. Cardenas, PhD, by the National Institutes of Health (NIH).
August 10, 2022
August is National Immunization Awareness Month, which is held to observe the importance and need for education about vaccines.
August 8, 2022
While research has revealed that children and adults hospitalized with COVID-19 are more susceptible to developing long COVID symptoms, a new study by researchers at UTHealth Houston found that children infected with COVID-19, but not hospitalized, still experienced long COVID symptoms up to three months past infection.
The study was published inThe Pediatric Infectious Disease Journal.
July 29, 2022
A study led by the lab ofMikhail Kolonin, PhD, professor and director of the Center for Metabolic and Degenerative Diseases in the Brown Foundation Institute of Molecular Medicine with McGovern Medical School at UTHealth Houston, has discovered a new molecular mechanism-controlling metabolism.
July 27, 2022
Kisha McClintock always knew she had a genetic predisposition for sickle cell disease, but it wasn’t until a cold night in December 2013 that the then 33-year-old woke from her sleep with severe pain in her left knee, sending McClintock to the emergency room and on a years-long search for answers.
July 20, 2022
An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chances of death, according to a new study fromUTHealth Houstonand other institutions.
July 20, 2022
People who are genetically at higher risk for stroke can lower that risk by as much as 43% by adopting a healthy cardiovascular lifestyle, according to new research led byUTHealth Houston, which was published today in theJournal of the American Heart Association.
July 15, 2022
During consultations with head and neck surgeons, a significantly higher proportion of patients who tested positive for COVID-19 were treated for nosebleeds compared to patients who tested negative for the virus, according to researchers at UTHealth Houston.
July 14, 2022
一部小说,疾病修饰治疗阿尔茨海默氏症disease may involve the whole exchange of blood, which effectively decreased the formation of amyloid plaque in the brains of mice, according to a new study fromUTHealth Houston.
July 12, 2022
Three families in three different states all share one thing in common – their children were diagnosed with spina bifida in utero.
Through their journey to find help, the families were referred to Ramesha Papanna, MD, a maternal-fetal surgeon withMcGovern Medical Schoolat UTHealth Houston andThe Fetal Center at Children's Memorial Hermann Hospital, where they enrolled in a one-of-a-kind fetoscopic spina bifida study using cryopreserved umbilical cord.
Use the form below to perform a new search.